Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07830147) titled 'HAIC Rechallenge in Biliary Tract Cancer and Colorectal Cancer Liver Metastases: Efficacy and Safety in Patients Resistant to Previous Systemic Chemotherapy' on Sept. 9.

Study Type: Observational

Primary Sponsor: West China Hospital

Condition: Biliary Tract Cancer

Intervention: Drug: Hepatic Arterial Infusion Chemotherapy (HAIC) Rechallenge

Recruitment Status: Not recruiting

Date of First Enrollment: January 2015

Target Sample Size: 72

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT07830147

Published by HT Digital Content Services with permission from Health Dail...